The Exchange has observed significant price/volume movement in following scrip/s in the recent past. The Exchange in order to ensure that trading member/investors have latest relevant information had written to the following company/ies. Reply received from them is attached herewith.

1.     AstraZeneca Pharma India Ltd (Scrip Code: 506820 )

2.     IM+ Capitals Ltd (Scrip Code: 511628 )

For & On behalf of BSE Ltd

Yogendra Daxini	Saji Sunilkumar
Assistant General Manager	Manager
Surveillance	Surveillance

13th Nov2020